By targeting a key molecular mechanism known to propagate AD pathogenesis, tau‐targeting nanoparticles have the potential to facilitate tau tangle clearance, promote synaptic integrity, and prevent excessive neuronal apoptosis. This evidence concerns the gene MAPT and Alzheimer disease.